NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Redesign Health

Redesign Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.redesignhealth.com/

Last Round

Venture Fund

Dec 12, 2024

Est. Valuation

$1.7B

Total Funding Raised

$165M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Redesign Health is a venture builder and investment firm that focuses on creating, launching, and scaling transformative healthcare companies.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, Telemedicine, Revenue Cycle, Compliance & Risk

Business Model

B2B2C

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

venture builderstartup studiohealthcare venture builderstartup factorycompany creationventure-building platformhealthcare startupsventure foundrycorporate venture buildingdigital healthequity-based modelseed fundingvalue-based carehealth equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redesign Health Comparables

Compare Redesign Health with similar companies based on industry and business-model similarity.

Redesign Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Agora Health
71%
Daya Ventures
69%
Ascertain
65%

Redesign Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Venture FundDec 12, 2024
Series CSep 13, 2022
Series BMar 25, 2021
VC RoundMar 25, 2021

Redesign Health Investors

Notable investors and investment history

Redesign Health investors
InvestorRounds
Aetna VenturesSeries C
TriplePoint CapitalSeries C
General CatalystSeries C
Samsung Next TLVSeries C
Eden Global AssociatesSeries C
CVS Health VenturesSeries C
Declaration PartnersSeries C, VC Round, Series B, Venture Fund

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Launched Digital Innovation Platform with Cedars-Sinai.

  • Apr 24, 2026

    Portfolio companies have impacted over 15 million patients since 2018.

Redesign Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Redesign Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redesign Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range272
Year Founded2018
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.